(Q36115287)

12 August 2017

Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study (English)

1 reference

12 August 2017

Segawa Y

1

1 reference

12 August 2017

Kageyama M

2

1 reference

12 August 2017

Suzuki S

3

1 reference

12 August 2017

Jinno K

4

1 reference

12 August 2017

Takigawa N

5

1 reference

12 August 2017

Fujimoto N

6

1 reference

12 August 2017

Hotta K

7

1 reference

12 August 2017

Eguchi K

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

78

1 reference

12 August 2017

5

1 reference

12 August 2017

667-672

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.557

12 August 2017

0 references

cites work

Clinical implications of the p53 tumor-suppressor gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

The relationship between serum p53 autoantibodies and characteristics of human breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

The p53 tumour suppressor gene

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

p53 mutations in human cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Analysis of the anti-p53 antibody response in cancer patients.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063056

Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer

21 October 2018

1 reference

12 December 2020

p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus

1 reference

12 December 2020

Clinical implications of the p53 tumor-suppressor gene

1 reference

12 December 2020

Serum p53 auto-antibodies: incidence in familial breast cancer

1 reference

12 December 2020

Serum p53 antibodies as early markers of lung cancer

1 reference

12 December 2020

Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation

1 reference

12 December 2020

Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.557

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

9744508

1 reference